IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i15p6493-d1208332.html
   My bibliography  Save this article

Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis

Author

Listed:
  • Gwenaëlle De Clifford-Faugère

    (Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, QC J9X 5E4, Canada)

  • Hermine Lore Nguena Nguefack

    (Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, QC J9X 5E4, Canada)

  • Manon Choinière

    (Research Center of the Centre Hospitalier de l’Université de Montréal, Montreal, QC H2X 0A9, Canada
    Department of Anesthesiology and Pain Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada)

  • M. Gabrielle Pagé

    (Research Center of the Centre Hospitalier de l’Université de Montréal, Montreal, QC H2X 0A9, Canada
    Department of Anesthesiology and Pain Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada)

  • Lucie Blais

    (Faculty of Pharmacy, Université de Montréal, Montreal, QC H3T 1J4, Canada)

  • Line Guénette

    (Faculty of Pharmacy, Université Laval, Québec, QC G1V 0A6, Canada
    Axe Santé des Populations et Pratiques Optimales en Santé, Centre de Recherche du CHU de Québec—Université Laval, Québec, QC G1V 4G2, Canada)

  • Marc Dorais

    (StatSciences Inc., Notre-Dame-de-l’Île-Perrot, QC J7V 0S2, Canada)

  • Anaïs Lacasse

    (Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, QC J9X 5E4, Canada)

Abstract

Background: In Canada, a state of health emergency was declared in May 2020 as a result of the COVID-19 pandemic. This study aimed to assess trends in the use of prescription medication for pain management by people living with chronic pain before and during the first wave of the pandemic. Methods: Participants (n = 177) were adults reporting chronic pain who had completed a web-based questionnaire in 2019 and for whom complete longitudinal private and public insurance prescription claims were available. The monthly prevalence of medication use for nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and prescribed cannabinoids was assessed. An interrupted time series analysis was then performed to evaluate if the COVID-19 pandemic had had an impact on trends in pain medication use. Results: The beginning of the first wave of the pandemic was associated with the onset of a downward trend in opioid use ( p < 0.05); no such association was found regarding NSAIDs. However, point prevalence of opioid use at the beginning (Nov. 2019) and at the end (Mai 2020) of the study period remained somewhat stable (17.0% vs. 16.4%). Regarding prescribed cannabinoids, a gradual increase in use was observed over the entire study period independently from the impact of the first wave of the pandemic (15.3% vs. 22.6%, p < 0.05). Conclusion: While the occurrence of the first wave did have an impact on opioid use among people living with chronic pain, access to and use of opioids appear to have returned to normal before the end of the first wave of COVID-19.

Suggested Citation

  • Gwenaëlle De Clifford-Faugère & Hermine Lore Nguena Nguefack & Manon Choinière & M. Gabrielle Pagé & Lucie Blais & Line Guénette & Marc Dorais & Anaïs Lacasse, 2023. "Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis," IJERPH, MDPI, vol. 20(15), pages 1-11, August.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:15:p:6493-:d:1208332
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/15/6493/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/15/6493/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Christian Kronborg & Gitte Handberg & Flemming Axelsen, 2009. "Health care costs, work productivity and activity impairment in non-malignant chronic pain patients," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 5-13, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Susanne Mayer & Jonah Spickschen & K Viktoria Stein & Richard Crevenna & Thomas E Dorner & Judit Simon, 2019. "The societal costs of chronic pain and its determinants: The case of Austria," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-18, March.
    2. Ziggi Ivan Santini & Hannah Becher & Maja Bæksgaard Jørgensen & Michael Davidsen & Line Nielsen & Carsten Hinrichsen & Katrine Rich Madsen & Charlotte Meilstrup & Ai Koyanagi & Sarah Stewart-Brown & D, 2021. "Economics of mental well-being: a prospective study estimating associated health care costs and sickness benefit transfers in Denmark," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(7), pages 1053-1065, September.
    3. Santini, Ziggi Ivan & Nielsen, Line & Hinrichsen, Carsten & Nelausen, Malene Kubstrup & Meilstrup, Charlotte & Koyanagi, Ai & McDaid, David & Lyubomirsky, Sonja & Vanderweele, Tyler J. & Koushede, Vib, 2021. "Mental health economics: a prospective study on psychological flourishing and associations with healthcare costs and sickness benefit transfers in Denmark," LSE Research Online Documents on Economics 112166, London School of Economics and Political Science, LSE Library.
    4. Paul S. J. Miller & Harry Hill & Fredrik L. Andersson, 2016. "Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic Diseases," PharmacoEconomics, Springer, vol. 34(12), pages 1277-1297, December.
    5. Luís Azevedo & Altamiro Costa-Pereira & Liliane Mendonça & Cláudia Dias & José Castro-Lopes, 2016. "The economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 87-98, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:15:p:6493-:d:1208332. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.